113 related articles for article (PubMed ID: 9828961)
1. The validation of statements by IDUs based on the analysis of blood traces on their used syringes.
Menoyo C; Lamikiz E; Zulaika D; Urcelai A; Zubia I; Martínez De Pancorbo M
AIDS Care; 1998 Aug; 10(4):409-14. PubMed ID: 9828961
[TBL] [Abstract][Full Text] [Related]
2. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
5. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
[TBL] [Abstract][Full Text] [Related]
6. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
8. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
[TBL] [Abstract][Full Text] [Related]
9. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
[TBL] [Abstract][Full Text] [Related]
10. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
11. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
14. Distributive syringe sharing among young adult injection drug users in five U.S. cities.
Golub ET; Strathdee SA; Bailey SL; Hagan H; Latka MH; Hudson SM; Garfein RS;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S30-8. PubMed ID: 17398039
[TBL] [Abstract][Full Text] [Related]
15. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F; Fatima M
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
[TBL] [Abstract][Full Text] [Related]
16. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
Tellado I; Moran N; Vargas Vidot J; Yamamura Y
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
[TBL] [Abstract][Full Text] [Related]
17. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
Ngo AD; Schmich L; Higgs P; Fischer A
Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
[TBL] [Abstract][Full Text] [Related]
18. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
[TBL] [Abstract][Full Text] [Related]
19. Strategies to improve access to sterile syringes for injection drug users.
Rich JD; Wolf FA; Macalino G
AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
[TBL] [Abstract][Full Text] [Related]
20. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
Shaw SY; Shah L; Jolly AM; Wylie JL
Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
